Nuclear hormone receptors for heme:: REV-ERBα and REV-ERBβ are ligand-regulated components of the mammalian clock

被引:124
|
作者
Burris, Thomas P. [1 ]
机构
[1] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Nucl Receptor Biol Lab, Baton Rouge, LA 70808 USA
关键词
D O I
10.1210/me.2007-0519
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nuclear hormone receptors (NHRs), REV-ERB alpha and REV-ERB beta, regulate a number of physiological functions including the circadian rhythm, lipid metabolism, and cellular differentiation. These two receptors lack the activation function-2 region that is associated with the ability of NHRs to recruit coactivators and activate target gene transcription. These NHRs have been characterized as constitutive repressors of transcription due to their lack of an identified ligand and their strong ability to recruit the corepressor, nuclear receptor corepressor. Recently, the porphyrin heme was demonstrated to function as a ligand for both REV-ERBs. Heme binds directly to the ligand-binding domain and regulates the ability of these NHRs to recruit nuclear receptor corepressor to target gene promoters. This review focuses on the physiological roles that these two receptors play and the implications of heme functioning as their ligand. The prospect that these NHRs, now known to be regulated by small molecule ligands, may be targets for development of drugs for treatment of diseases associated with aberrant circadian rhythms including metabolic and psychiatric disorders as well as cancer is also addressed.
引用
收藏
页码:1509 / 1520
页数:12
相关论文
共 50 条
  • [41] Rev-erbα gives a time cue to metabolism
    Duez, Helene
    Staels, Bart
    [J]. FEBS LETTERS, 2008, 582 (01) : 19 - 25
  • [42] Suppression of atherosclerosis by synthetic REV-ERB agonist
    Sitaula, Sadichha
    Billon, Cyrielle
    Kamenecka, Theodore M.
    Solt, Laura A.
    Burris, Thomas P.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (03) : 566 - 571
  • [43] The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication
    Zhuang, Xiaodong
    Magri, Andrea
    Hill, Michelle
    Lai, Alvina G.
    Kumar, Abhinav
    Rambhatla, Srinivasa Bhargav
    Donald, Claire L.
    Lopez-Clavijo, Andrea F.
    Rudge, Simon
    Pinnick, Katherine
    Chang, Wai Hoong
    Wing, Peter A. C.
    Brown, Ryan
    Qin, Ximing
    Simmonds, Peter
    Baumert, Thomas F.
    Ray, David
    Loudon, Andrew
    Balfe, Peter
    Wakelam, Michael
    Butterworth, Sam
    Kohl, Alain
    Jopling, Catherine L.
    Zitzmann, Nicole
    McKeating, Jane A.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [44] Nuclear receptor Rev-erbα: up, down, and all around
    Everett, Logan J.
    Lazar, Mitchell A.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2014, 25 (11): : 586 - 592
  • [45] Inhibition of Rev-erbα ameliorates muscular dystrophy
    Xiong, Xuekai
    Gao, Hongbo
    Lin, Yayu
    Yechoor, Vijay
    Ma, Ke
    [J]. EXPERIMENTAL CELL RESEARCH, 2021, 406 (02)
  • [46] REV-ERB is essential in cardiac fibroblasts homeostasis
    Luo, Xiaokang
    Song, Shiyang
    Qi, Lei
    Tien, Chih-Liang
    Li, Hui
    Xu, Weiyi
    Mathuram, Theodore Lemuel
    Burris, Thomas
    Zhao, Yuanbiao
    Sun, Zheng
    Zhang, Lilei
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] A Role for Rev-erbα Ligands in the Regulation of Adipogenesis
    Kojetin, Douglas J.
    Burris, Thomas P.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (04) : 320 - 324
  • [48] Rev-erb and the circadian transcriptional regulation of metabolism
    Gerhart-Hines, Z.
    Lazar, M. A.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 : 12 - 16
  • [49] Investigating REV-ERB and ROR as drug targets
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (06) : 573 - 573
  • [50] Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα
    Altman, Brian J.
    Hsieh, Annie L.
    Gouw, Arvin M.
    Dang, Chi V.
    [J]. NATURE COMMUNICATIONS, 2017, 8